Drugs / G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02790515 Background | Jul 2016 → Jul 2025 overdue | acute lymphoblastic leukemia, chronic myeloid leukemia, juvenile myelomonocytic leukemia, myelodysplastic syndrome +1 | St. Jude Children's Research Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02790515 ↗ |
| Route | Intravenous | “Given IV or subcutaneous (SQ) following transplant on Days 6 and 7.” NCT02790515 ↗ |
| Route | Subcutaneous | “Given IV or subcutaneous (SQ) following transplant on Days 6 and 7.” NCT02790515 ↗ |